Helport AI Advances Transition to Autonomous AI Labor in Southeast Asian Fintech Market Noram Announces New Resource Estimate for Zeus Lithium Deposit Preliminary Economic Assessment Underway and in Final Stages
VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Noram Lithium Corp. (“Noram” or the…
Relief’s Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Data Published in Peer Reviewed Journal, Nutrients, Indicating Additional Potential Benefits of Its Physiomimic(TM) Technology
Data In Healthy Volunteers Suggests That APR’s Controlled Release Amino Acid Mix, PKU GOLIKE(R) ,…
Iken Business Ltd and Bundledocs announce software integration
Iken Cloud expands the client experience through the integration with market leading document bundling provider…
Broadband boost for small and medium MDUs across Europe and North America as InCoax unveils its D2501
Operators will be able to extend XGS-PON or Active Ethernet fiber and manage services through…
Forsta Names Brian Bhuta as Chief Product Officer
Accomplished product executive to spearhead innovation across the newly merged company’s suite of CX insights…
Climate action and carbon neutrality: ClimatePartner introduces solutions for companies of all sizes and industries
Proven SaaS solution enables companies to take immediate climate action Established and acknowledged solution for…
World premiere: Viva Frida Kahlo – Immersive Experience
The first museum for immersive art in Switzerland is opening with a world premiere: Viva…
Codasip opens UK Design Center led by Simon Bewick
Over one hundred engineers to be hired in multiple locations Munich Germany, September 21st, 2021…
Tim Dargavel Joins The Zylpha Bundling Development Team
Tim Dargavel has joined the UK’s most innovative legal document bundling group Zylpha (www.Zylpha.com) as…
Hyloris Announces Further Extension of Maxigesic® IV Footprint
Regulatory approvals in South Korea, the fourth largest pharma market in Asia, and Panama Maxigesic®…
Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer
REGULATED INFORMATION Gosselies, Belgium, 21 September 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris:…
New Dupixent® (dupilumab) data in patients as young as 6 years old with moderate-to-severe atopic dermatitis to be presented at WCPD and EADV
New Dupixent® (dupilumab) data in patients as young as 6 years old with moderate-to-severe atopic…
Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock and Preferred Stock
WALTHAM, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical…
Second Industry Body Updates Guidance for Use of PSMA PET Imaging
MELBOURNE, Australia and INDIANAPOLIS, Sept. 20, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX,…
HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA® in Combination with TUOYI® in the Treatment of Advanced Neuroendocrine Carcinoma in China
HONG KONG and FLORHAM PARK, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited…
Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer
TIVDAK is a First-in-Class Antibody-Drug Conjugate Directed to Tissue Factor, a Protein Expressed on Cervical…
XORTX Therapeutics Announces Share Consolidation
CALGARY, Alberta, Sept. 20, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…
Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors
FOSTER CITY, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
BOSTON, Sept. 20, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
Immuneering Announces Inclusion in the Russell 2000® Index
CAMBRIDGE, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company…